Copyright Reports & Markets. All rights reserved.

Global Oral Blood Glucose Regulators Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Oral Blood Glucose Regulators Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Biguanides
    • 1.3.3 Sulfonylureas
    • 1.3.4 Meglitinides
    • 1.3.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
    • 1.3.6 SGLT2 Inhibitors
    • 1.3.7 Thiazolidinediones
    • 1.3.8 Alpha-Glucosidase Inhibitors
    • 1.3.9 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Oral Blood Glucose Regulators Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Oral Blood Glucose Regulators Market Size & Forecast
    • 1.5.1 Global Oral Blood Glucose Regulators Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Oral Blood Glucose Regulators Sales Quantity (2021-2032)
    • 1.5.3 Global Oral Blood Glucose Regulators Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Oral Blood Glucose Regulators Product and Services
    • 2.1.4 Bayer Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Oral Blood Glucose Regulators Product and Services
    • 2.2.4 Merck Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Oral Blood Glucose Regulators Product and Services
    • 2.3.4 Novartis Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 Huadong Medicine
    • 2.4.1 Huadong Medicine Details
    • 2.4.2 Huadong Medicine Major Business
    • 2.4.3 Huadong Medicine Oral Blood Glucose Regulators Product and Services
    • 2.4.4 Huadong Medicine Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Huadong Medicine Recent Developments/Updates
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi Oral Blood Glucose Regulators Product and Services
    • 2.5.4 Sanofi Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sanofi Recent Developments/Updates
  • 2.6 Novo Nordisk
    • 2.6.1 Novo Nordisk Details
    • 2.6.2 Novo Nordisk Major Business
    • 2.6.3 Novo Nordisk Oral Blood Glucose Regulators Product and Services
    • 2.6.4 Novo Nordisk Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Novo Nordisk Recent Developments/Updates
  • 2.7 Servier
    • 2.7.1 Servier Details
    • 2.7.2 Servier Major Business
    • 2.7.3 Servier Oral Blood Glucose Regulators Product and Services
    • 2.7.4 Servier Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Servier Recent Developments/Updates
  • 2.8 Takeda Pharmaceutical
    • 2.8.1 Takeda Pharmaceutical Details
    • 2.8.2 Takeda Pharmaceutical Major Business
    • 2.8.3 Takeda Pharmaceutical Oral Blood Glucose Regulators Product and Services
    • 2.8.4 Takeda Pharmaceutical Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Takeda Pharmaceutical Recent Developments/Updates
  • 2.9 Luye Pharmaceutical
    • 2.9.1 Luye Pharmaceutical Details
    • 2.9.2 Luye Pharmaceutical Major Business
    • 2.9.3 Luye Pharmaceutical Oral Blood Glucose Regulators Product and Services
    • 2.9.4 Luye Pharmaceutical Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Luye Pharmaceutical Recent Developments/Updates
  • 2.10 Taiji Group
    • 2.10.1 Taiji Group Details
    • 2.10.2 Taiji Group Major Business
    • 2.10.3 Taiji Group Oral Blood Glucose Regulators Product and Services
    • 2.10.4 Taiji Group Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Taiji Group Recent Developments/Updates
  • 2.11 CR Double-Crane
    • 2.11.1 CR Double-Crane Details
    • 2.11.2 CR Double-Crane Major Business
    • 2.11.3 CR Double-Crane Oral Blood Glucose Regulators Product and Services
    • 2.11.4 CR Double-Crane Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 CR Double-Crane Recent Developments/Updates
  • 2.12 AstraZeneca
    • 2.12.1 AstraZeneca Details
    • 2.12.2 AstraZeneca Major Business
    • 2.12.3 AstraZeneca Oral Blood Glucose Regulators Product and Services
    • 2.12.4 AstraZeneca Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 AstraZeneca Recent Developments/Updates
  • 2.13 Boehringer Ingelheim
    • 2.13.1 Boehringer Ingelheim Details
    • 2.13.2 Boehringer Ingelheim Major Business
    • 2.13.3 Boehringer Ingelheim Oral Blood Glucose Regulators Product and Services
    • 2.13.4 Boehringer Ingelheim Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.14 Qilu Pharmaceutical
    • 2.14.1 Qilu Pharmaceutical Details
    • 2.14.2 Qilu Pharmaceutical Major Business
    • 2.14.3 Qilu Pharmaceutical Oral Blood Glucose Regulators Product and Services
    • 2.14.4 Qilu Pharmaceutical Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.15 Jiangsu Deyuan Pharmaceutical
    • 2.15.1 Jiangsu Deyuan Pharmaceutical Details
    • 2.15.2 Jiangsu Deyuan Pharmaceutical Major Business
    • 2.15.3 Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Product and Services
    • 2.15.4 Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
  • 2.16 CTTQ
    • 2.16.1 CTTQ Details
    • 2.16.2 CTTQ Major Business
    • 2.16.3 CTTQ Oral Blood Glucose Regulators Product and Services
    • 2.16.4 CTTQ Oral Blood Glucose Regulators Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 CTTQ Recent Developments/Updates

3 Competitive Environment: Oral Blood Glucose Regulators by Manufacturer

  • 3.1 Global Oral Blood Glucose Regulators Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Oral Blood Glucose Regulators Revenue by Manufacturer (2021-2026)
  • 3.3 Global Oral Blood Glucose Regulators Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Oral Blood Glucose Regulators by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Oral Blood Glucose Regulators Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Oral Blood Glucose Regulators Manufacturer Market Share in 2025
  • 3.5 Oral Blood Glucose Regulators Market: Overall Company Footprint Analysis
    • 3.5.1 Oral Blood Glucose Regulators Market: Region Footprint
    • 3.5.2 Oral Blood Glucose Regulators Market: Company Product Type Footprint
    • 3.5.3 Oral Blood Glucose Regulators Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Oral Blood Glucose Regulators Market Size by Region
    • 4.1.1 Global Oral Blood Glucose Regulators Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Oral Blood Glucose Regulators Consumption Value by Region (2021-2032)
    • 4.1.3 Global Oral Blood Glucose Regulators Average Price by Region (2021-2032)
  • 4.2 North America Oral Blood Glucose Regulators Consumption Value (2021-2032)
  • 4.3 Europe Oral Blood Glucose Regulators Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Oral Blood Glucose Regulators Consumption Value (2021-2032)
  • 4.5 South America Oral Blood Glucose Regulators Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Oral Blood Glucose Regulators Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Oral Blood Glucose Regulators Sales Quantity by Type (2021-2032)
  • 5.2 Global Oral Blood Glucose Regulators Consumption Value by Type (2021-2032)
  • 5.3 Global Oral Blood Glucose Regulators Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Oral Blood Glucose Regulators Sales Quantity by Application (2021-2032)
  • 6.2 Global Oral Blood Glucose Regulators Consumption Value by Application (2021-2032)
  • 6.3 Global Oral Blood Glucose Regulators Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Oral Blood Glucose Regulators Sales Quantity by Type (2021-2032)
  • 7.2 North America Oral Blood Glucose Regulators Sales Quantity by Application (2021-2032)
  • 7.3 North America Oral Blood Glucose Regulators Market Size by Country
    • 7.3.1 North America Oral Blood Glucose Regulators Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Oral Blood Glucose Regulators Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Oral Blood Glucose Regulators Sales Quantity by Type (2021-2032)
  • 8.2 Europe Oral Blood Glucose Regulators Sales Quantity by Application (2021-2032)
  • 8.3 Europe Oral Blood Glucose Regulators Market Size by Country
    • 8.3.1 Europe Oral Blood Glucose Regulators Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Oral Blood Glucose Regulators Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Oral Blood Glucose Regulators Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Oral Blood Glucose Regulators Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Oral Blood Glucose Regulators Market Size by Region
    • 9.3.1 Asia-Pacific Oral Blood Glucose Regulators Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Oral Blood Glucose Regulators Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Oral Blood Glucose Regulators Sales Quantity by Type (2021-2032)
  • 10.2 South America Oral Blood Glucose Regulators Sales Quantity by Application (2021-2032)
  • 10.3 South America Oral Blood Glucose Regulators Market Size by Country
    • 10.3.1 South America Oral Blood Glucose Regulators Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Oral Blood Glucose Regulators Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Oral Blood Glucose Regulators Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Oral Blood Glucose Regulators Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Oral Blood Glucose Regulators Market Size by Country
    • 11.3.1 Middle East & Africa Oral Blood Glucose Regulators Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Oral Blood Glucose Regulators Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Oral Blood Glucose Regulators Market Drivers
  • 12.2 Oral Blood Glucose Regulators Market Restraints
  • 12.3 Oral Blood Glucose Regulators Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Oral Blood Glucose Regulators and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Oral Blood Glucose Regulators
  • 13.3 Oral Blood Glucose Regulators Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Oral Blood Glucose Regulators Typical Distributors
  • 14.3 Oral Blood Glucose Regulators Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Oral Blood Glucose Regulators market size was valued at US$ 82120 million in 2025 and is forecast to a readjusted size of US$ 184330 million by 2032 with a CAGR of 12.4% during review period.
    Oral Blood Glucose Regulators are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Oral Blood Glucose Regulators market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oral Blood Glucose Regulators market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Blood Glucose Regulators market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Blood Glucose Regulators market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oral Blood Glucose Regulators market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oral Blood Glucose Regulators
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oral Blood Glucose Regulators market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical, Luye Pharmaceutical, Taiji Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Oral Blood Glucose Regulators market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Biguanides
    Sulfonylureas
    Meglitinides
    Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
    SGLT2 Inhibitors
    Thiazolidinediones
    Alpha-Glucosidase Inhibitors
    Other
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Bayer
    Merck
    Novartis
    Huadong Medicine
    Sanofi
    Novo Nordisk
    Servier
    Takeda Pharmaceutical
    Luye Pharmaceutical
    Taiji Group
    CR Double-Crane
    AstraZeneca
    Boehringer Ingelheim
    Qilu Pharmaceutical
    Jiangsu Deyuan Pharmaceutical
    CTTQ
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Oral Blood Glucose Regulators product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Oral Blood Glucose Regulators, with price, sales quantity, revenue, and global market share of Oral Blood Glucose Regulators from 2021 to 2026.
    Chapter 3, the Oral Blood Glucose Regulators competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Oral Blood Glucose Regulators breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Blood Glucose Regulators market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Blood Glucose Regulators.
    Chapter 14 and 15, to describe Oral Blood Glucose Regulators sales channel, distributors, customers, research findings and conclusion.

    Buy now